{"tid":1983147,"cid":5,"subCid":10,"title":"納瓦羅：中國為搶先研發疫苗獲利，拒給武漢肺炎資料","createTime":"2020-04-21T15:24:46.000Z","updateTime":"2020-04-21T15:25:09.000Z","uid":75656,"like":5,"dislike":0,"uniUserReply":2,"replies":[{"pid":"fc81991b755e397b980d3011e43583ad5bd583c5","tid":1983147,"uid":75656,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-04-21T15:24:46.000Z","msg":"〔編譯魏國金／綜合報導〕路透報導，白宮顧問納瓦洛20日指控說，中國可能因希望在生產疫苗的商業競賽上取勝而拒絕提供早期武漢肺炎感染的資料。<br />\n<br />\n淪為武肺災情最慘重國家的美國，一再呼籲北京分享疫情爆發時的早期資料。納瓦洛告訴福斯商業新聞網（Fox Business Network）說，「他們不讓我們進入（疫情發源地武漢），提早給予我們該病毒資料的一個原因是他們搶著取得疫苗，他們認為這是一門競爭性的商業競賽，這是商業觀點，他們能將疫苗行銷全球」。<br />\n<br />\n「因為川普總統的領導，我們將擊敗他們」。納瓦洛並提到美國衛生與公共服務部已與5家公司合作研發疫苗。川普已任命納瓦洛負責與武肺流行有關的供應鏈議題。<br />\n<br />\n<a href=\"https://ec.ltn.com.tw/article/breakingnews/3140726\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fec.ltn.com.tw%2Farticle%2Fbreakingnews%2F3140726&d=ltyh5TmdzGcNJFTF%2BAmR8ogDU6S0x1vJ5b5MQMl6fZo%3D&h=013b98d1\" data-ef-url=\"https://embed.lih.kg/frame?u=https%3A%2F%2Fec.ltn.com.tw%2Farticle%2Fbreakingnews%2F3140726&h=6f3f40df\" target=\"_blank\">https://ec.ltn.com.tw/article/breakingnews/3140726</a><br />\n<br />\nfox news:<a href=\"https://video.foxnews.com/v/6150753972001#sp=show-clips\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fvideo.foxnews.com%2Fv%2F6150753972001%23sp%3Dshow-clips&d=ltyh5TmdzGcNJFTF%2BAmR8ogDU6S0x1vJ5b5MQMl6fZo%3D&h=c85d8c6a\" data-ef-url=\"https://embed.lih.kg/frame?u=https%3A%2F%2Fvideo.foxnews.com%2Fv%2F6150753972001%23sp%3Dshow-clips&h=33e0a12e\" data-auto-link target=\"_blank\">https://video.foxnews.com/v/6150753972001#sp=show-clips</a>"},{"pid":"cd79dbea7eace7ace1c8b3ea3aa1a65ff365dd8e","tid":1983147,"uid":265839,"like":1,"dislike":0,"score":1,"citedBy":0,"replyTime":"2020-04-21T15:25:09.000Z","msg":"地球毒瘤"}]}